相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors
Matthew J. Mosquera et al.
ADVANCED MATERIALS (2022)
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Guido Rindi et al.
ENDOCRINE PATHOLOGY (2022)
SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas
Neali Armstrong et al.
CELL REPORTS (2022)
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy
Fabrice Viol et al.
CELLULAR ONCOLOGY (2022)
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors
Simon Leonhard April-Monn et al.
NEUROENDOCRINOLOGY (2021)
Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions
Katharina Detjen et al.
NEUROENDOCRINOLOGY (2021)
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer
Michael J. Giffin et al.
CLINICAL CANCER RESEARCH (2021)
Model systems in SDHx-related pheochromocytoma/paraganglioma
Krisztina Takacs-Vellai et al.
CANCER AND METASTASIS REVIEWS (2021)
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer
Neha Singh et al.
NATURE COMMUNICATIONS (2021)
Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma
Krijn K. Dijkstra et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13
Kosuke Okasho et al.
CANCER SCIENCE (2021)
Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
Angela M. Carter et al.
ONCOGENESIS (2021)
Molecular events in neuroendocrine prostate cancer development
Yong Wang et al.
NATURE REVIEWS UROLOGY (2021)
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
Gail P. Risbridger et al.
NATURE COMMUNICATIONS (2021)
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids
Nicholas Choo et al.
SLAS DISCOVERY (2021)
Two well-differentiated pancreatic neuroendocrine tumor mouse models
Chung Wong et al.
CELL DEATH AND DIFFERENTIATION (2020)
IGF2 drives formation of ileal neuroendocrine tumors in patients and mice
Tanupriya Contractor et al.
ENDOCRINE-RELATED CANCER (2020)
Pre-clinical models of small cell lung cancer and the validation of therapeutic targets
Jane S. Y. Sui et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
Zu-Yi Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model
Vincent Faugeroux et al.
NATURE COMMUNICATIONS (2020)
Genetic background influences tumour development in heterozygous Men1 knockout mice
Kate E. Lines et al.
ENDOCRINE CONNECTIONS (2020)
Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10
William H. Gmeiner et al.
CANCERS (2020)
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development
Nallasivam Palanisamy et al.
CLINICAL CANCER RESEARCH (2020)
A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb plus /- rats
James F. Powers et al.
ENDOCRINE-RELATED CANCER (2020)
Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors
Yuki Yamauchi et al.
CANCER RESEARCH (2020)
Report of the use of patient-derived xenograft models in the development of anticancer drugs in Japan
Ryo Tsumura et al.
CANCER SCIENCE (2020)
An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping
Kenta Kawasaki et al.
CELL (2020)
Mouse models of endocrine tumors
Manuel D. Gahete et al.
JOURNAL OF ENDOCRINOLOGY (2019)
Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line
Kazuyoshi Yanagihara et al.
Oncotarget (2019)
Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors
Shinta Kobayashi et al.
ONCOGENESIS (2019)
A Transgenic Mouse Model of Pacak-Zhuang Syndrome with An Epas1 Gain-of-Function Mutation
Herui Wang et al.
CANCERS (2019)
Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'
Mariano J. Alvarez et al.
NATURE GENETICS (2019)
Establishment and characterization of a novel neuroendocrine carcinoma cell line derived from a human ascending colon tumor
Seiichi Shinji et al.
CANCER SCIENCE (2019)
Clinical features of neuroendocrine prostate cancer
Vincenza Conteduca et al.
EUROPEAN JOURNAL OF CANCER (2019)
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim et al.
NATURE COMMUNICATIONS (2019)
Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms
Robert T. Jensen et al.
NEUROENDOCRINOLOGY (2019)
Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
Kenta Kawasaki et al.
DISEASE MODELS & MECHANISMS (2018)
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
Tobias Hofving et al.
ENDOCRINE-RELATED CANCER (2018)
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma
Edmund C. P. Chedgy et al.
JOURNAL OF PATHOLOGY (2018)
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
Daniel Benten et al.
MOLECULAR CANCER RESEARCH (2018)
Establishment and Characterization of a Novel Cell Line Derived from a Small Cell Neuroendocrine Carcinoma of the Anal Canal
Levent Dizdar et al.
NEUROENDOCRINOLOGY (2018)
Patient derived organoids to model rare prostate cancer phenotypes
Loredana Puca et al.
NATURE COMMUNICATIONS (2018)
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
Mitchell G. Lawrence et al.
EUROPEAN UROLOGY (2018)
A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors
Chester E. Chamberlain et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line
Michael Gock et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma
Kazuyoshi Yanagihara et al.
Oncotarget (2018)
A Zebrafish Acromegaly Model Elevates DNA Damage and Impairs DNA Repair Pathways
Abdalla Elbialy et al.
BIOLOGY-BASEL (2018)
Genetically engineered mouse models in oncology research and cancer medicine
Kelly Kersten et al.
EMBO MOLECULAR MEDICINE (2017)
Pathology of Human Pheochromocytoma and Paraganglioma Xenografts in NSG Mice
James F. Powers et al.
ENDOCRINE PATHOLOGY (2017)
Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids
Sinju Sundaresan et al.
GUT (2017)
Translational research in neuroendocrine tumors: pitfalls and opportunities
J. Capdevila et al.
ONCOGENE (2017)
Establishment of a tumor sphere cell line from a metastatic brain neuroendocrine tumor
Ryoichi Iwata et al.
MEDICAL MOLECULAR MORPHOLOGY (2017)
Biology and evolution of poorly differentiated neuroendocrine tumors
David S. Rickman et al.
NATURE MEDICINE (2017)
Effects of PPARα inhibition in head and neck paraganglioma cells
Rosalba Florio et al.
PLOS ONE (2017)
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
Holly M. Nguyen et al.
PROSTATE (2017)
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Bryan Oronsky et al.
NEOPLASIA (2017)
A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control
K. E. Lines et al.
ENDOCRINE CONNECTIONS (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Small-cell lung cancer: what we know, what we need to know and the path forward
Adi F. Gazdar et al.
NATURE REVIEWS CANCER (2017)
Classification of pulmonary neuroendocrine tumors: new insights
Giuseppe Pelosi et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors
Germano Gaudenzi et al.
ENDOCRINE (2017)
Principles of diagnosis and management of neuroendocrine tumours
Michael J. Raphael et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
Masayuki Fujii et al.
CELL STEM CELL (2016)
Establishment and Characterization of a Human Neuroendocrine Tumor Xenograft
Zhaoying Yang et al.
ENDOCRINE PATHOLOGY (2016)
Genetics of neuroendocrine tumors
Joakim Crona et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma
Charlotte Lepoutre-Lussey et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
Geoffrey Wayne Krampitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cells
Yamei Chen et al.
ONCOTARGET (2016)
A Novel Zebrafish ret Heterozygous Model of Hirschsprung Disease Identifies a Functional Role for mapk10 as a Modifier of Enteric Nervous System Phenotype Severity
Tiffany A. Heanue et al.
PLOS GENETICS (2016)
p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells
Stephanie Azzopardi et al.
NEOPLASIA (2016)
Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer
T. Parisi et al.
ONCOGENE (2015)
Initiation and Characterization of Small Cell Lung Cancer Patient-Derived Xenografts from Ultrasound-Guided Transbronchial Needle Aspirates
Wade C. Anderson et al.
PLOS ONE (2015)
Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines
Ganesh K. Boora et al.
CANCER GENETICS (2015)
Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model
Jiahua Jiang et al.
ONCOTARGET (2015)
Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides
Yuko Takano et al.
PLOS ONE (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
David G. McFadden et al.
CELL (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess
Liz Bentley et al.
ENDOCRINOLOGY (2014)
Islets of Langerhans from prohormone convertase-2 knockout mice show α-cell hyperplasia and tumorigenesis with elevated α-cell neogenesis
Huw B. Jones et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2014)
p19INk4d Is a Tumor Suppressor and Controls Pituitary Anterior Lobe Cell Proliferation
Feng Bai et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
Rajesh V. Thakker
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Activating BRAF and PIK3CA Mutations Cooperate to Promote Anaplastic Thyroid Carcinogenesis
Roch-Philippe Charles et al.
MOLECULAR CANCER RESEARCH (2014)
PTEN Is a Potent Suppressor of Small Cell Lung Cancer
Min Cui et al.
MOLECULAR CANCER RESEARCH (2014)
Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma
S. T. Glenn et al.
ONCOGENE (2014)
New Model for Gastroenteropancreatic Large-Cell Neuroendocrine Carcinoma: Establishment of Two Clinically Relevant Cell Lines
Andreas Krieg et al.
PLOS ONE (2014)
Clinical Presentation and Evaluation of Neuroendocrine Tumors of the Lung
Frank C. Detterbeck
THORACIC SURGERY CLINICS (2014)
Synergistic Signaling of KRAS and Thyroid Hormone Receptor β Mutants Promotes Undifferentiated Thyroid Cancer through MYC Up-Regulation
Xuguang Zhu et al.
NEOPLASIA (2014)
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling
Alessandro Cama et al.
ACTA NEUROPATHOLOGICA (2013)
The Role of Cdk5 in Neuroendocrine Thyroid Cancer
Karine Pozo et al.
CANCER CELL (2013)
Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent
Emilia M. Pinto et al.
CLINICAL CANCER RESEARCH (2013)
Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor
Hans K. Ghayee et al.
PLOS ONE (2013)
A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
Lianhai Zhang et al.
SCIENTIFIC REPORTS (2013)
Conditional deletion of menin results in antral G cell hyperplasia and hypergastrinemia
Natalia A. Veniaminova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Shizhen Zhu et al.
CANCER CELL (2012)
Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
Vassiliki Tzelepi et al.
CLINICAL CANCER RESEARCH (2012)
Murine Models and Cell Lines for the Investigation of Pheochromocytoma: Applications for Future Therapies?
Esther Korpershoek et al.
ENDOCRINE PATHOLOGY (2012)
Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer
Daphne R. Pringle et al.
ENDOCRINE-RELATED CANCER (2012)
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models
Mallika Singh et al.
JOURNAL OF PATHOLOGY (2012)
Expression of a Neuroendocrine Gene Signature in Gastric Tumor Cells from CEA 424-SV40 Large T Antigen-Transgenic Mice Depends on SV40 Large T Antigen
Fritz Ihler et al.
PLOS ONE (2012)
Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model
Thomas J. Quinn et al.
SURGERY (2012)
Cytoplasmic CUL9/PARC Ubiquitin Ligase Is a Tumor Suppressor and Promotes p53-Dependent Apoptosis
Xin-Hai Pei et al.
CANCER RESEARCH (2011)
Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin
Seok-Hyung Kim et al.
DISEASE MODELS & MECHANISMS (2011)
Pioglitazone Induces a Proadipogenic Antitumor Response in Mice with PAX8-PPARγ Fusion Protein Thyroid Carcinoma
Melissa E. Dobson et al.
ENDOCRINOLOGY (2011)
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
Debyani Chakravarty et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Mouse models for inherited endocrine and metabolic disorders
Sian E. Piret et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Establishment and Characterization of a New Cell Line, A99, From a Primary Small Cell Carcinoma of the Pancreas
Shinichi Yachida et al.
PANCREAS (2011)
Pancreatic Neuroendocrine Tumors in Glucagon Receptor-Deficient Mice
Run Yu et al.
PLOS ONE (2011)
Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
Ning-Ai Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Neuroendocrine Prostate Cancer Xenografts With Large-Cell and Small-Cell Features Derived From a Single Patient's Tumor: Morphological, Immunohistochemical, and Gene Expression Profiles
Ana Aparicio et al.
PROSTATE (2011)
Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors
Valeria G. Antico Arciuch et al.
ONCOTARGET (2011)
Zebrafish usp39 Mutation Leads to rb1 mRNA Splicing Defect and Pituitary Lineage Expansion
Yesenia Rios et al.
PLOS GENETICS (2011)
Mice with Inactivation of Aryl Hydrocarbon Receptor-Interacting Protein (Aip) Display Complete Penetrance of Pituitary Adenomas with Aberrant ARNT Expression
Anniina Raitila et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?
Lluis-A. Lopez-Barcons
ASIAN JOURNAL OF ANDROLOGY (2010)
Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma
Bethany E. Schaffer et al.
CANCER RESEARCH (2010)
A bioluminescent mouse model of pancreatic β-cell carcinogenesis
Adrian Zumsteg et al.
CARCINOGENESIS (2010)
von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish
Ellen van Rooijen et al.
DISEASE MODELS & MECHANISMS (2010)
Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin
Bristi Basu et al.
ENDOCRINE-RELATED CANCER (2010)
Multiple Endocrine Neoplasia Type 1 Deletion in Pancreatic α-Cells Leads to Development of Insulinomas in Mice
H. -C. Jennifer Shen et al.
ENDOCRINOLOGY (2010)
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[F-18]F-L-DOPA
Carine Pestourie et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
α Cell-Specific Men1 Ablation Triggers the Transdifferentiation of Glucagon-Expressing Cells and Insulinoma Development
Jieli Lu et al.
GASTROENTEROLOGY (2010)
Cooperation between Cyclin E and p27Kip1 in Pituitary Tumorigenesis
Audrey Roussel-Gervais et al.
MOLECULAR ENDOCRINOLOGY (2010)
Spectral Karyotypic and Comparative Genomic Analysis of the Endocrine Pancreatic Tumor Cell Line BON-1
Juan R. Lopez et al.
NEUROENDOCRINOLOGY (2010)
Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females
V. G. Antico-Arciuch et al.
ONCOGENE (2010)
The immune response to sporadic colorectal cancer in a novel mouse model
M. Czeh et al.
ONCOGENE (2010)
Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis
Matthew G. H. Chun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Recapitulation of Pancreatic Neuroendocrine Tumors in Human Multiple Endocrine Neoplasia Type I Syndrome via Pdx1-Directed Inactivation of Men1
H. -C. Jennifer Shen et al.
CANCER RESEARCH (2009)
Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia
Brian Harding et al.
ENDOCRINE-RELATED CANCER (2009)
KRJ-I and BON Cell Lines: Defining an Appropriate Enterochromaffin Cell Neuroendocrine Tumor Model
Zakiya-Luna Siddique et al.
NEUROENDOCRINOLOGY (2009)
Genetic model system studies of the development of the enteric nervous system, gut motility and Hirschsprung's disease
G. Burzynski et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
H. -C. Jennifer Shen et al.
PLOS ONE (2009)
Sdhd and Sdhd/H19 Knockout Mice Do Not Develop Paraganglioma or Pheochromocytoma
Jean-Pierre Bayley et al.
PLOS ONE (2009)
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
David C. Metz et al.
GASTROENTEROLOGY (2008)
The CM cell line derived from liver metastasis of malignant human insulinoma is not a valid beta cell model for in vitro studies
Claudia Gragnoli
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation
Samira Alliouachene et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Pituitary-specific knockout of the carney complex gene Prkar1a leads to pituitary tumorigenesis
Zhirong Yin et al.
MOLECULAR ENDOCRINOLOGY (2008)
Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts
Lilach Agemy et al.
PROSTATE (2008)
Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice
Teresita Reiner et al.
MOLECULAR CANCER RESEARCH (2007)
The development and characterization of a human midgut carcinoid cell line
George Van Buren et al.
CLINICAL CANCER RESEARCH (2007)
Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice
K. A. Loffler et al.
ONCOGENE (2007)
Pten loss in the mouse thyroid causes goiter and follicular adenomas:: Insights into thyroid function and Cowden disease pathogenesis
Nicole Yeager et al.
CANCER RESEARCH (2007)
Pituitary tumor transforming gene overexpression facilitates pituitary tumor development
Ines Donangelo et al.
ENDOCRINOLOGY (2006)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis
Cynthia J. Guidi et al.
CANCER RESEARCH (2006)
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas
D. Vitagliano et al.
ONCOGENE (2006)
Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis
V Chesnokova et al.
MOLECULAR ENDOCRINOLOGY (2005)
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell
M Fedele et al.
ONCOGENE (2005)
Early multipotential pituitary focal hyperplasia in the α-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice
RA Abbud et al.
MOLECULAR ENDOCRINOLOGY (2005)
A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies
MY Gabril et al.
MOLECULAR THERAPY (2005)
Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model
WM Duan et al.
ONCOGENE (2005)
Conditional inactivation of the Men1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues
CA Biondi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A transgenic mouse model of metastatic carcinoma. involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype
AJ Syder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Hepsin promotes prostate cancer progression and metastasis
O Klezovitch et al.
CANCER CELL (2004)
cAMP-dependent oncogenic action of Rap1b in the thyroid gland
F Ribeiro-Neto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2)
C Jimenez et al.
GROWTH HORMONE & IGF RESEARCH (2004)
Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish
WY Hong et al.
CANCER RESEARCH (2004)
The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer
BC Lewis et al.
GENES & DEVELOPMENT (2003)
Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1
P Bertolino et al.
MOLECULAR ENDOCRINOLOGY (2003)
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
R Meuwissen et al.
CANCER CELL (2003)
Of mice and MEN1: Insulinomas in a conditional mouse knockout
JS Crabtree et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
CA Neumann et al.
NATURE (2003)
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model
PJ Kaplan-Lefko et al.
PROSTATE (2003)
Genetic ablation of the tumor suppresor menin causes lethality at mid-gestation with defects in multiple organs
P Bertolino et al.
MECHANISMS OF DEVELOPMENT (2003)
Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice
RW Gelling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
ARF mutation accelerates pituitary tumor development in Rb± mice
KY Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model
MY Gabril et al.
GENE THERAPY (2002)
Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma:: A mouse model of thyroid carcinogenesis
H Suzuki et al.
THYROID (2002)
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas
M Fedele et al.
ONCOGENE (2002)
Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression
S Pelengaris et al.
CELL (2002)
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice
MJ You et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Targeting and conditional inactivation of the murine Men1 locus using the Cre recombinase:: LoxP system
C Biondi et al.
GENESIS (2002)
Pituitary hyperplasia in glycoprotein hormone alpha subunit-, p18(INK4C)-, and p27(kip-1)-null mice - Analysis of proteins influencing p27(kip-1) ubiquitin degradation
RV Lloyd et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors
R Sotillo et al.
EMBO JOURNAL (2001)
Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα
RL Tuttle et al.
NATURE MEDICINE (2001)
Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53 mice
DJ Powell et al.
ONCOGENE (2001)
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
JS Crabtree et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Isolation, maintenance, and characterization of human pancreatic islet tumor cells expressing vasoactive intestinal peptide
LG Tillotson et al.
PANCREAS (2001)
Morphometric analysis of CC10-hASH1 transgenic mouse lung: A model for bronchiolization of alveoli and neuroendocrine carcinoma
RI Linnoila et al.
EXPERIMENTAL LUNG RESEARCH (2000)
The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium
JP Russell et al.
ONCOGENE (2000)
Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas
KMD La Perle et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice
DS Acton et al.
ONCOGENE (2000)
C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B
CL Smith-Hicks et al.
EMBO JOURNAL (2000)
Establishment and characterization of two new rectal neuroendocrine cell carcinoma cell lines
Y Takahashi et al.
DIGESTION (2000)
分享论文
